Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of Immunic Inc (NASDAQ: IMUX) was $0.96 for the day, down -1.82% from the previous closing price of $0.98. In other words, the price has decreased by -$1.82 from its previous closing price. On the day, 0.64 million shares were traded. IMUX stock price reached its highest trading level at $0.9999 during the session, while it also had its lowest trading level at $0.95.
Ratios:
Our analysis of IMUX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.74.
On November 25, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $10.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 13 ’25 when Nash Duane bought 20,000 shares for $0.83 per share. The transaction valued at 16,694 led to the insider holds 36,032 shares of the business.
Tardio Jason bought 12,512 shares of IMUX for $9,884 on Jun 05 ’25. The President and COO now owns 12,512 shares after completing the transaction at $0.79 per share. On Jun 04 ’25, another insider, Vitt Daniel, who serves as the CEO and Director of the company, bought 15,000 shares for $0.77 each. As a result, the insider paid 11,550 and bolstered with 29,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMUX now has a Market Capitalization of 92128528 and an Enterprise Value of 78799560.
Stock Price History:
The Beta on a monthly basis for IMUX is 1.41, which has changed by -0.31285715 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is 14.77%, while the 200-Day Moving Average is calculated to be -8.46%.
Shares Statistics:
IMUX traded an average of 1.84M shares per day over the past three months and 1431930 shares per day over the past ten days. A total of 95.82M shares are outstanding, with a floating share count of 92.55M. Insiders hold about 3.42% of the company’s shares, while institutions hold 47.84% stake in the company. Shares short for IMUX as of 1752537600 were 8564101 with a Short Ratio of 4.67, compared to 1749772800 on 7442140. Therefore, it implies a Short% of Shares Outstanding of 8564101 and a Short% of Float of 9.11.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 7.0 analysts are dedicated to thoroughly evaluating and rating the performance of Immunic Inc (IMUX) in the stock market.The consensus estimate for the next quarter is -$0.16, with high estimates of -$0.05 and low estimates of -$0.26.
Analysts are recommending an EPS of between -$0.39 and -$1.02 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is -$0.57, with 6.0 analysts recommending between -$0.18 and -$0.94.
